
Sign up to save your podcasts
Or


Two new cancer care initiatives -- Medicare's Enhancing Oncology Model and the Patient-Centered Cancer Care Certification from the American Society of Clinical Oncology, or ASCO -- aim to improve patient outcomes and fight rising costs.
Both initiatives have lofty goals, but can they attain them? And how will they impact manufacturers and market access?
Today's guest is John Hennessy, Senior Vice President, Strategist with Valuate Health Consultancy.
The IDI is presented by Valuate Health Consultancy.
Follow Valuate on LinkedIn to learn more.
Prescription digital therapeutics is a promising new technology for patients with chronic conditions. But it comes with challenges too. Christine Castiglione, MPH, a Senior Strategy Analyst with Valuate Health Consultancy, offers her insights on prescription digital therapeutics.
Connect with guest Christine Castiglione.
Learn more about Valuate Health.
John Hennessy, SVP of Strategy with Valuate Health Consultancy, is well known and highly respected for his experience in cancer care. In this episode, Hennessy discusses the high cost of cancer care -- and how manufacturers, payers and clinicians are trying to address it. He also reports back from the American Society of Clinical Oncology's first in-person meeting in two years.
BONUS: John weighs in on the big Supreme Court decision on 340B payments.
The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.
What's happening in specialty pharmacy and coverage? Derek Tancredi, MBA, has some thoughts. He just returned from Asembia 2022 and heard from payers, pharmacists, Dr. Scott Gottlieb, and more.
The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.
Kimberly Tsai, PharmD, and Christine Castiglione, MPH, report back from AMCP 2022 in Part Two of a special podcast.
In Part Two, Kimberly and Christine discuss the PIE Act, social determinants of health, and more.
The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.
Kimberly Tsai, PharmD, and Christine Castiglione, MPH, report back from AMCP 2022 in the first of a two-part special podcast.
AMCP, presented by the Academy of Managed Care Pharmacy, is a major event in the world of pharma and market access – and there’s always lots of news and takeaways for market access professionals.
In Part One of a two-episode wrap-up, Kimberly and Christine reveal their biggest takeaways from AMCP and delve into biosimilars and why their time may finally be here.
The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.
From the publisher's feed